Login / Signup

Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke.

Jelle DemeestereMuhammad M QureshiLieselotte VandewalleAnke WoutersStrbian DanielRaul Gomes NogueiraSimon NagelHiroshi YamagamiVolker PuetzMohamad AbdalkaderDiogo C HaussenMahmoud H MohammadenMarkus A MöhlenbruchMarta Olive GadeaSimon WinzerMarc RiboPatrik MichelJoão Pedro MartoKanta TanakaShinichi YoshimuraNicolas Martinez-MajanderFrancois CaparrosHilde HénonLiisa TomppoAnne DusartFlavio BellanteJoão Nuno RamosJessica JesserSunil A ShethSantiago Ortega GutierrezJames E SieglerStefania NannoniJohannes KaesmacherTomas DobrockySergio Salazar-MarioniMudassir FarooquiPekka VirtanenRita Monteiro VenturaSyed F ZaidiAlicia C CastonguayKazutaka UchidaAjit S PuriNobuyuki SakaiKazunori ToyodaBezhad FarzinHesham E MasoudPiers KleinJenny BuiFederica RizzoDaniel P O KaiserPhilippe DesfontainesDavide StramboCharlotte CordonnierEugene LinPeter Arthur RinglebDaniel RoyOsama O ZaidatUrs FischerJean RaymondRobin LemmensThanh N Nguyen
Published in: Stroke (2024)
URL: https://www.clinicaltrials.gov; Unique identifier: NCT04096248.
Keyphrases
  • acute ischemic stroke
  • high dose
  • cell therapy
  • mesenchymal stem cells
  • glycemic control